PGEN (Precigen) Inventories, Finished Goods: $1.69 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PGEN Precigen Inc PGEN
55 GF Score
Price $6.89
GF Value $6.04
Valuation Modestly Overvalued
! 10 Warning Signs
View Full Analysis

What is Precigen Inventories, Finished Goods?

Precigen PGEN +5.67% 55 Inventories, Finished Goods is $1.69 Mil as of Jun. 2026. GuruFocus rates PGEN with a GF Score™ of 55/100 and a GF Value™ of $6.04 (Modestly Overvalued). The stock has 10 warning signs investors should review.

Precigen's quarterly finished goods increased from Dec. 2025 ($0.17 Mil) to Mar. 2026 ($1.31 Mil) and increased from Mar. 2026 ($1.31 Mil) to Jun. 2026 ($1.69 Mil).

Precigen's annual finished goods stayed the same from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.00 Mil) but then increased from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($0.17 Mil).

Precigen Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Precigen's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Precigen Inventories, Finished Goods Chart

Precigen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.17

Precigen Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.17 1.31 1.69
PGEN
55GF Score
Precigen Inc PGEN
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Precigen Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of $1.69 Mil mean?
Precigen (PGEN) has a Inventories, Finished Goods of $1.69 Mil as of Jun. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Precigen and its competitors.
Is Precigen's Inventories, Finished Goods too high?
Precigen's current Inventories, Finished Goods is $1.69 Mil. Overall, Precigen has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Precigen's Inventories, Finished Goods compare to GLUE and ZBIO?
Precigen's Inventories, Finished Goods of $1.69 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Biotechnology company?
A good Inventories, Finished Goods depends on the Biotechnology industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Precigen and its competitors. Precigen's current Inventories, Finished Goods is $1.69 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Precigen stock overvalued right now?
Based on GuruFocus' analysis, Precigen (PGEN) is currently considered Modestly Overvalued. The stock's GF Value™ is $6.04, compared to a current price of $6.89 — trading 14.1% above its estimated fair value. The current Inventories, Finished Goods is $1.69 Mil. Precigen's overall GF Score™ is 55/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Precigen (PGEN), the current Inventories, Finished Goods is $1.69 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Precigen (PGEN) Overvalued in 2026?

Based on GuruFocus' analysis, Precigen stock appears to be overvalued. The current stock price of $6.89 is trading 14.1% above its estimated GF Value™ of $6.04. GuruFocus considers Precigen to be Modestly Overvalued.

Key valuation signals for PGEN:

  • Inventories, Finished Goods: $1.69 Mil
  • GF Value™: $6.04 vs. price of $6.89 (14.1% above fair value)
  • GF Score™: 55/100 with 10 warning signs

No single metric tells the full story. See the PGEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Precigen Business Description

Other Exchanges I5X:Germany
Address 20374 Seneca Meadows Parkway, Germantown, MD, USA, 20876
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
55GF Score

Get the complete analysis for PGEN

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.89
Price
$6.04
GF Value